NEKTAR THERAPEUTICS NEKTAR THER (0UNL.L) Financials
0UNL.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 442.2 million | 282.9 million |
2023-06-30 | 494.3 million | 297.3 million |
2023-03-31 | 561.7 million | 320.9 million |
2022-12-31 | 710.6 million | 344.0 million |
0UNL.L Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -42.2 million | 8.1 million |
2023-06-30 | -51.7 million | 8.0 million |
2023-03-31 | -52.3 million | 10.0 million |
2022-12-31 | -58.2 million | 12.7 million |
0UNL.L Net Income
No data available :(
0UNL.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 372.7 million | - | - |
2023-06-30 | 409.4 million | - | - |
2023-03-31 | 456.8 million | - | - |
2022-12-31 | 505.0 million | - | - |
0UNL.L Shares Outstanding
0UNL.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 33000 | 24.1 million | 21.1 million | - |
2023-06-30 | 162000 | 29.7 million | 17.9 million | - |
2023-03-31 | 433000 | 30.5 million | 21.1 million | - |
2022-12-31 | 512000 | 34.7 million | 21.9 million | - |
0UNL.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 24.1 million | 12.4 million |
2023-06-30 | 20.5 million | 7.0 million |
2023-03-31 | 21.6 million | 7.1 million |
2022-12-31 | 22.0 million | 6.2 million |
0UNL.L
Price: $1.74
52 week price:
Earnings Per Share: -2.66 USD
P/E Ratio: -0.27
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 3.1 million